Systemic lupus erythematosus (SLE) is a complex autoimmune process with the potential to detrimentally impact every organ system in the human body. According to Dr. Michelle Petri, up to two-thirds of SLE cases are due to genetic predisposition, with SLE being more prevalent and severe among African- and Hispanic-Americans. The remaining one-third of cases may be attributed to environmental and hormonal components, with women being affected more than men in a 9:1 ratio. The implications of SLE are far-reaching, and it is important to develop a greater understanding of the disease to further improve current diagnostic and management strategies.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More